uniQure N.V. Operating Leases, Rent Expense
uniQure N.V. (QURE) reported Operating Leases, Rent Expense of $1.10 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2017-08-08
- uniQure N.V. operating leases, rent expense for the quarter ending 2017-06-30 was $1.10M, a 0.00% change year-over-year.
- uniQure N.V. operating leases, rent expense for the quarter ending 2017-03-31 was $1.00M, a 25.00% increase year-over-year.
- uniQure N.V. operating leases, rent expense for the quarter ending 2016-06-30 was $1.10M.
- uniQure N.V. operating leases, rent expense for the quarter ending 2016-03-31 was $800.00K.
- uniQure N.V. operating leases, rent expense for fiscal 2016 was $4.40M, a 144.44% increase from fiscal 2015.
- uniQure N.V. operating leases, rent expense for fiscal 2015 was $1.80M, a 20.00% increase from fiscal 2014.
- uniQure N.V. operating leases, rent expense for fiscal 2014 was $1.50M.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|
| 2017-06-30 | $1.10M 10-Q · filed 2017-08-08 | $2.10M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.00M 10-Q · filed 2017-05-09 | ||
| 2016-12-31 | $4.40M 10-K · filed 2017-03-15 | ||
| 2016-06-30 | $1.10M 10-Q · filed 2017-08-08 | $1.90M 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $800.00K 10-Q · filed 2017-05-09 | ||
| 2015-12-31 | $1.80M 10-K · filed 2017-03-15 | ||
| 2014-12-31 | $1.50M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |